Don't Assume DOACs are Preferred for All Patients with Venous Thromboembolism

March 2016

We're getting questions about which anticoagulant to use to TREAT venous thromboembolism (VTE).

New guidelines give preference to direct oral anticoagulants (DOACs)...such as Eliquis (apixaban) or Xarelto (rivaroxaban).

But don't assume that DOACs are the best choice for everyone.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter membership benefits include:

12 issues every year — what you need to know and do, right now
Quick, practical reference charts and tools
Comprehensive CE library to meet license renewal and state requirements
Multiple course formats including live webinars, podcasts, and CE-in-the-Letter to match your learning style
Plus much more!

Choose the right tier for your needs today.

Already a subscriber? Log in

Volume pricing available. Get a quote